Abstract: An examination apparatus for medical examination, in particular determination of a blood pressure, of an animal, in particular an animal having a paw, particularly preferably an animal from the subfamily of the Felinae. The examination apparatus has a sensor device for the optical examination of an arterial blood flow of the animal, in particular for performing a photoplethysmography. For this purpose, the sensor device has at least one emitter for the emission of electromagnetic radiation and at least one detector for the detection of the radiation emitted by the emitter. The sensor device preferably has several emitters and several detectors that are arranged in a periodic structure. Alternatively or additionally, the sensor device has a limiting device which defines a border of a detection region of the sensor device so that a distance of the border from the sensor device is more than 0.5 mm and/or less than 5 mm.

Abstract: A method for medical examination, in particular determination of the blood pressure of an animal that preferably has a paw and is in particular an animal of the subfamily of the Felinae. In the method, a curve comprising information about the arterial blood flow of the animal, in particular a photoplethysmogram, is recorded, and the curve is cut into several curve sections in such a way that each curve section corresponds to a heartbeat. According to another independent aspect, a sensor or a subset of sensors is selected from several sensors of the same kind to perform the examination.

Abstract: A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.

Abstract: A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.